Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127960261 | 12796026 | 1 | I | 201602 | 20160307 | 20160929 | 20160929 | PER | US-INCYTE CORPORATION-2016IN001370 | INCYTE | 62.92 | YR | M | Y | 0.00000 | 20160929 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127960261 | 12796026 | 1 | PS | JAKAFI | RUXOLITINIB | 1 | Oral | 10 MG, BID | U | AD6458P | 0 | 10 | MG | TABLET | BID | ||||
| 127960261 | 12796026 | 2 | SS | PEGASYS | PEGINTERFERON ALFA-2A | 1 | Unknown | UNK | 0 | ||||||||||
| 127960261 | 12796026 | 3 | C | THYROXINE | LEVOTHYROXINE | 1 | Unknown | UNK | 0 | ||||||||||
| 127960261 | 12796026 | 4 | C | FINASTERIDE. | FINASTERIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 127960261 | 12796026 | 5 | C | FLUTICASONE | FLUTICASONEFLUTICASONE PROPIONATE | 1 | Unknown | UNK | 0 | ||||||||||
| 127960261 | 12796026 | 6 | C | TAMSULOSIN | TAMSULOSIN | 1 | Unknown | UNK | 0 | ||||||||||
| 127960261 | 12796026 | 7 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 127960261 | 12796026 | 8 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Unknown | PRN | 0 | ||||||||||
| 127960261 | 12796026 | 9 | C | CALCIUM | CALCIUM | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127960261 | 12796026 | 1 | Myelofibrosis |
| 127960261 | 12796026 | 2 | Product used for unknown indication |
| 127960261 | 12796026 | 3 | Product used for unknown indication |
| 127960261 | 12796026 | 4 | Product used for unknown indication |
| 127960261 | 12796026 | 5 | Product used for unknown indication |
| 127960261 | 12796026 | 6 | Product used for unknown indication |
| 127960261 | 12796026 | 7 | Product used for unknown indication |
| 127960261 | 12796026 | 8 | Sleep disorder |
| 127960261 | 12796026 | 9 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127960261 | 12796026 | Influenza like illness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127960261 | 12796026 | 1 | 2016 | 0 |